$116.50

0.00 (0.00%)
Live
Previous Close

$116.5

Day Range

$0 - $0

Previous Day Range

$115.76 - $118.86

Market Cap

$6.7 billion USD

Day Vol.

0

Previous Day Vol.

754697

Currency

USD

Primary Exchange

Nasdaq

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vacc...


Community
  • 0 posts discussing
0

Watchers

0

Visitors


Recent News

Repligen, a bioprocessing technology company, reported mixed Q4 results. While adjusted EPS exceeded expectations, GAAP gross margin declined significantly due to restructuring and other costs. The company is focused on product innovations and strategic acquisitions to drive growth.

Related tickers: RGEN.

Read Full Article

The global chromatography system market is expected to grow at a CAGR of 6.6% from 2024 to 2034, driven by increasing applications in the biotechnology sector and technological advancements that simplify procedures and reduce human error.

Related tickers: BIO, BIO.B, TMO, A, WAT, RGEN, BRKR.

Read Full Article
Trending Tickers

Please sign in to view